Skip to Main Content

Author Details

Derek S Chiu
University of British Columbia, and Vancouver General Hospital
2016
31
15
PMIDPaper TitleJournal TitlePublished Year
36368129Profiling the immune landscape in mucinous ovarian carcinoma.Gynecol Oncol2023
37182372Corrigendum to "Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death": [Modern Pathology 36 (2023) 100085].Mod Pathol2023
37339172The Prognostic Effect of Immune Cell Infiltration Depends on Molecular Subtype in Endometrioid Ovarian Carcinomas.Clin Cancer Res2023
36753816Molecular subtype stratified outcomes according to adjuvant therapy in endometrial cancer.Gynecol Oncol2023
36788084Grade and Estrogen Receptor Expression Identify a Subset of No Specific Molecular Profile Endometrial Carcinomas at a Very Low Risk of Disease-Specific Death.Mod Pathol2023
36735436Symptom and Anatomical Phenotypes Provide Insights Into Interactions of Prolapse Symptoms and Anatomy.Urogynecology (Phila)2023
36731023Targeted Molecular Testing in Endometrial Carcinoma: Validation of a Clinically Driven Selective ProMisE Testing Protocol.Int J Gynecol Pathol2023
34782936MCM3 is a novel proliferation marker associated with longer survival for patients with tubo-ovarian high-grade serous carcinoma.Virchows Arch2022
35768582Molecular characterization of low-grade serous ovarian carcinoma identifies genomic aberrations according to hormone receptor expression.NPJ Precis Oncol2022
35860688Wearable Biosensors in the Workplace: Perceptions and Perspectives.Front Digit Health2022
36031730The proteome of clear cell ovarian carcinoma.J Pathol2022
36222710Gene-Expression Profiling of Mucinous Ovarian Tumors and Comparison with Upper and Lower Gastrointestinal Tumors Identifies Markers Associated with Adverse Outcomes.Clin Cancer Res2022
35246332Variation in practice in endometrial cancer and potential for improved care and equity through molecular classification.Gynecol Oncol2022
34897700Validated biomarker assays confirm that ARID1A loss is confounded with MMR deficiency, CD8<sup>+</sup> TIL infiltration, and provides no independent prognostic value in endometriosis-associated ovarian carcinomas.J Pathol2022
33165093Clinicopathologic Characteristics of Mesonephric Adenocarcinomas and Mesonephric-like Adenocarcinomas in the Gynecologic Tract: A Multi-institutional Study.Am J Surg Pathol2021
33793971Evaluation of treatment effects in patients with endometrial cancer and POLE mutations: An individual patient data meta-analysis.Cancer2021
33709473Quantitative imaging of RAD51 expression as a marker of platinum resistance in ovarian cancer.EMBO Mol Med2021
32473302Prognostic gene expression signature for high-grade serous ovarian cancer.Ann Oncol2020
35121983Age-correlated protein and transcript expression in breast cancer and normal breast tissues is dominated by host endocrine effects.Nat Cancer2020
31954537Hormone receptor expression and outcomes in low-grade serous ovarian carcinoma.Gynecol Oncol2020
32094924TMEM30A loss-of-function mutations drive lymphomagenesis and confer therapeutically exploitable vulnerability in B-cell lymphoma.Nat Med2020
32686118Synthesis of diagnostic quality cancer pathology images by generative adversarial networks.J Pathol2020
32737030Endometrial Cancer Molecular Risk Stratification is Equally Prognostic for Endometrioid Ovarian Carcinoma.Clin Cancer Res2020
32554541Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE).Clin Cancer Res2020
30720532Clinical Outcomes of HPV-associated and Unassociated Endocervical Adenocarcinomas Categorized by the International Endocervical Adenocarcinoma Criteria and Classification (IECC).Am J Surg Pathol2019
31187483Oncogenic mutations in histologically normal endometrium: the new normal?J Pathol2019
29334888diceR: an R package for class discovery using an ensemble driven approach.BMC Bioinformatics2018
27601594Neoadjuvant Chemotherapy of Ovarian Cancer Results in Three Patterns of Tumor-Infiltrating Lymphocyte Response with Distinct Implications for Immunotherapy.Clin Cancer Res2017
28211448CX-5461 is a DNA G-quadruplex stabilizer with selective lethality in BRCA1/2 deficient tumours.Nat Commun2017
26763250Endometrial Carcinomas with POLE Exonuclease Domain Mutations Have a Favorable Prognosis.Clin Cancer Res2016
27096160Single-Patient Molecular Testing with NanoString nCounter Data Using a Reference-Based Strategy for Batch Effect Correction.PLoS One2016
  • 1 - 31 of 31

Recommended Authors

Pier Selenica
Memorial Sloan Kettering Cancer Center
Career Start Year 2017
Number of shared co-authors 5
Arnaud Da Cruz Paula
Memorial Sloan Kettering Cancer Center
Career Start Year 2014
Number of shared co-authors 5
Cathleen Matrai
Weill Cornell Medical Center
Career Start Year 2013
Number of shared co-authors 0
Ekaterina Olkhov-Mitsel
University of Toronto
Career Start Year 2012
Number of shared co-authors 0
Francis Nguyen
Ontario Institute for Cancer Research
Career Start Year 2012
Number of shared co-authors 2
Yuexin Liu
The University of Texas MD Anderson Cancer Center
Career Start Year 2011
Number of shared co-authors 7
Ghassan Allo
Henry Ford Hospital
Career Start Year 2011
Number of shared co-authors 12
Eloise Chapman-Davis
Weill Cornell Medical College
Career Start Year 2009
Number of shared co-authors 0
Darragh G McArt
Queen's University Belfast
Career Start Year 2009
Number of shared co-authors 0
Myriam Kossai
INSERM, Universite Clermont Auvergne
Career Start Year 2008
Number of shared co-authors 0
Justin Guinney
University of Washington
Career Start Year 2006
Number of shared co-authors 4
Markus Riester
Novartis Institutes for BioMedical Research
Career Start Year 2005
Number of shared co-authors 2
Christina Yau
University of California San Francisco
Career Start Year 2005
Number of shared co-authors 6
Donal J Brennan
National Centre for Peritoneal Malignancy, Mater Misericordiae University Hospital
Career Start Year 2005
Number of shared co-authors 23
Leah M Prentice
British Columbia Women's Hospital and Health Centre
Career Start Year 2004
Number of shared co-authors 43
Andrew H Beck
Beth Israel Deaconess Medical Center, Harvard Medical School
Career Start Year 2004
Number of shared co-authors 18
Katherine A Hoadley
Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 11
Jennifer B Permuth
Moffitt Cancer Center
Career Start Year 2004
Number of shared co-authors 70
Benjamin Haibe-Kains
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2004
Number of shared co-authors 8
Leslie Cope
Johns Hopkins University School of Medicine
Career Start Year 2003
Number of shared co-authors 4
Britta Weigelt
Memorial Sloan Kettering Cancer Center
Career Start Year 2002
Number of shared co-authors 30
Frederick Klauschen
Institute of Pathology, Ludwig-Maximilians-Universitat Munchen
Career Start Year 2002
Number of shared co-authors 5
Joel S Parker
Lineberger Cancer Center, University of North Carolina
Career Start Year 2002
Number of shared co-authors 7
Richard B Schwab
Department of Medicine and Moores Cancer Center, University of California San Diego
Career Start Year 2000
Number of shared co-authors 0
Lodewyk F A Wessels
University Medical Centre Mannheim, University of Heidelberg
Career Start Year 2000
Number of shared co-authors 20
Susan C Modesitt
University of Virginia, Emily Couric Clinical Cancer Center
Career Start Year 1998
Number of shared co-authors 3
Jan Budczies
Institute of Pathology, University Hospital Heidelberg
Career Start Year 1996
Number of shared co-authors 3
Kathleen M Darcy
The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc.
Career Start Year 1990
Number of shared co-authors 57
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 0
Ronny Drapkin
University of Pennsylvania School of Medicine
Career Start Year 1980
Number of shared co-authors 66

Collaborators

Aline Talhouk
The University of British Columbia
Co-authored papers 23
Cyril B Gilks
University of British Columbia
Co-authored papers 17
David G Huntsman
University of British Columbia
Co-authored papers 16
Martin K??bel
University of Calgary
Co-authored papers 15
Samuel Leung
University of British Columbia
Co-authored papers 14
Stefan Kommoss
Eberhard Karls University Tubingen
Co-authored papers 13
Michael S Anglesio
University of British Columbia
Co-authored papers 11
Susan J Ramus
School of Clinical Medicine, University of NSW Sydney, Lowy Cancer Research Centre
Co-authored papers 8
Anna DeFazio
Westmead Hospital
Co-authored papers 7
Naveena Singh
Barts Health NHS Trust
Co-authored papers 7
Amy Lum
University of British Columbia
Co-authored papers 7
Malcolm C Pike
Memorial Sloan-Kettering Cancer Center
Co-authored papers 6
Janine Senz
University of British Columbia
Co-authored papers 6
Paul D P Pharoah
Center for Cancer Genetic Epidemiology, University of Cambridge
Co-authored papers 6
James D Brenton
CRUK Cambridge Institute, University of Cambridge
Co-authored papers 6
Celeste Leigh Pearce
University of Michigan School of Public Health ann arbor
Co-authored papers 6
Catherine J Kennedy
The Westmead Institute for Medical Research, University of Sydney
Co-authored papers 6
Ellen L Goode
Mayo Clinic College of Medicine
Co-authored papers 6
Linda E Kelemen
Hollings Cancer Center, Medical University of South Carolina
Co-authored papers 5
Hans-Peter Sinn
Pathologisches Institut, Universitatsklinikum Heidelberg
Co-authored papers 5
David D L Bowtell
Peter MacCallum Cancer Centre
Co-authored papers 5
Kara L Cushing-Haugen
Fred Hutchinson Cancer Center
Co-authored papers 5
Tayyebeh M Nazeran
University of British Columbia
Co-authored papers 5
Jacek Gronwald
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 5
Simon A Gayther
Cedars-Sinai Medical Center
Co-authored papers 5
Jennifer Alsop
University of Cambridge
Co-authored papers 5
Holly R Harris
Fred Hutchinson Cancer Center, University of Washington
Co-authored papers 5
Mercedes Jimenez-Linan
University of Cambridge
Co-authored papers 5
Cezary Cybulski
International Hereditary Cancer Center, Pomeranian Medical University
Co-authored papers 4
Helen Steed
University of Alberta, Canada Cross Cancer Institute
Co-authored papers 4
Release 1.2